On December 16, 2022, Clinomics Inc. closed the transaction. Each preferred stock is convertible into 2,749,266 shares at a fixed conversion price of KRW 10,912 per share.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,436 KRW | +5.51% | -11.36% | -44.02% |
1st Jan change | Capi. | |
---|---|---|
-44.02% | 34.81M | |
+29.77% | 49.46B | |
+1.00% | 42.58B | |
+49.73% | 42.49B | |
-5.26% | 29.09B | |
+13.68% | 26.61B | |
-22.99% | 18.64B | |
+8.22% | 13.16B | |
+32.41% | 12.55B | |
+24.01% | 12.1B |
- Stock Market
- Equities
- A352770 Stock
- News Clinomics Inc.
- Clinomics Inc. announced that it has received KRW 2.99999694 billion in funding